Cost minimization analysis of Herceptin subcutaneous versus Herceptin intravenous treatment for patients with HER2+ Breast cancer in Greece
| Autor: | Mylonas, C., Skroumpelos, A., Fountzilas, G., Maniadakis, N. |
|---|---|
| Zdroj: | In Journal of Cancer Policy September 2017 13:11-17 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect